Study to Assess Clinical Characteristics and Outcome of Patients with Marginal Zone Lymphomas

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna

About this trial

This is a purely retrospective and observational monocentric study

Marginal zone lymphoma patients who were diagnosed and treated in our Hospital between December 2012 and December 2018.

Age ≥ 18 years at enrolment.

Written informed consent (if applicable)

none

No trial groups listed

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Lead sponsor